TY  - GEN
AU  - Corazzelli,G
AU  - Russo,F
AU  - Capobianco,G
AU  - Marcacci,G
AU  - Della Cioppa,P
AU  - Pinto,A
TI  - Gemcitabine, ifosfamide, oxaliplatin and rituximab (R-GIFOX), a new effective cytoreductive/mobilizing salvage regimen for relapsed and refractory aggressive non-Hodgkin's lymphoma: results of a pilot study
SN  - 0923-7534
PY  - 2006///1114
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Murine-Derived
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Combined Modality Therapy
KW  - Deoxycytidine
KW  - Disease-Free Survival
KW  - Female
KW  - Hematopoietic Stem Cell Mobilization
KW  - Humans
KW  - Ifosfamide
KW  - Lymphoma, B-Cell
KW  - pathology
KW  - Lymphoma, Follicular
KW  - Lymphoma, Large B-Cell, Diffuse
KW  - Lymphoma, Mantle-Cell
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Recurrence, Local
KW  - Organoplatinum Compounds
KW  - Oxaliplatin
KW  - Pilot Projects
KW  - Remission Induction
KW  - Rituximab
KW  - Salvage Therapy
KW  - Stem Cell Transplantation
KW  - Survival Rate
KW  - Transplantation, Autologous
KW  - Treatment Outcome
KW  - Gemcitabine
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1093/annonc/mdj994
ER  -